Shanghai yizhong latest announcement: signed a market promotion service agreement with Baiyang Pharmaceutical

2022-05-28 0 By

Shanghai Yizhong announced that under the marketing mode mainly based on independent marketing, the company and Baiyang Pharmaceutical recently reached a cooperation consensus on the promotion of paclitaxel polymer micelles for injection in designated areas outside its own operation and signed a “Marketing Service Agreement”, which will become an important supplement to the company’s existing marketing mode.The chairman of the board is Zhou Jinsong.Mr. Zhou Jinsong, born in December 1968, is a Chinese national, a member of the Communist Party of China (CPC), without the right of permanent residence abroad, with a master’s degree, an economist.From September 1986 to July 1990, studied at School of Power Engineering, Harbin Institute of Technology, with a BACHELOR’s degree.From September 1995 to March 1998, I studied in School of Management Engineering, Zhejiang University and got a master’s degree.He used to be the head of the investment department of Zhejiang Pharmaceutical Co., LTD., the executive director of Apel, the founder of Shanghai Yizhong, and now the chairman and general manager of the publisher.As the core founder of the company, he has presided over a number of national and Shanghai major science and technology projects, including 2 national major new drug creation projects, 5 Shanghai municipal science and technology projects, and 2 invention patents have been applied for and granted.In 2013, he was awarded the honorary title of “Binhai Sage — Leading Talent” by Shanghai Fengxian District Talent Work Leading Group.The above content is compiled by Securities Star according to public information, if you have any questions, please contact us.